Atlas Arteria (ASX: ALX) announced that it has completed the fully underwritten Placement (which was oversubscribed) and the institutional component of the 4 for 21 pro-rata accelerated non-renounceable entitlement offer of new ordinary stapled securities.
- The offer was announced to global and domestic sophisticated, professional and other institutional investors raising ~$1.2 billion.
- Settlement of the Placement and institutional component of the Entitlement Offer is scheduled to take place on 2 December 2019, and the next day, allotment and quotation of the new securities on ASX is expected to occur.
At AEST (1:12 PM), ALX quoted $7.795, up by 2% from the previous close.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.